Showing 1111-1120 of 1319 results for "".
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN1107epilepsy-pdf/31101/Febrile seizures are a prevalent neurological concern in pediatric populations, affecting approximately 4% of children in the United States. Typically occurring between one month and five years of age, with a peak incidence at 18 to 22 months, these seizures are triggered by febrile illnesses rather
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn0607-painmanagemnt-pdf/31166/Herbal Supplements Pose Significant Risks in Neurological CareHerbal supplements, often perceived as natural and safe, present considerable risks for patients undergoing neurological treatments. Dr. Charles Argoff, in Practical Neurology, highlights the critical need for healthcare professionals to
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0107DementiaInsight-pdf/31225/Linking Physical Activity to Cognitive Health in AgingRecent insights published in Practical Neurology highlight the significant relationship between physical activity and cognitive health in older adults, underscoring the potential to mitigate cognitive decline and reduce dementia risk through acti
- A Century of Alzheimer's: Progress and Pitfallshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/pn1106-100years-pdf/31244/Alzheimer’s disease (AD), first identified by Alois Alzheimer in 1906 through the examination of Auguste D.’s brain, has evolved into one of the most extensively studied neurological disorders. Despite over a century of research, AD remains challenging to predict, diagnose accurately in living patie
- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31258/Medicare’s projected 5.1% reimbursement cuts for 2007 have reignited concerns among neurologists and other medical specialists about significant financial strain. If these cuts proceed as planned, physicians could see their earnings reduced by up to 40% by 2015. These reductions highlight underlying
- Are You Overlooking Diabetic Neuropathy?https://practicalneurology.com/columns/practice-management/are-you-overlooking-diabetic-neuropathy/31289/Emerging Strategies in Managing Diabetic Peripheral Neuropathic PainDiabetic peripheral neuropathic pain (DPNP) is becoming increasingly prevalent in the United States, with an estimated 20.8 million individuals diagnosed with diabetes mellitus as of 2005. As diabetes rates rise due to an aging popu
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0606Epilepsy-pdf/31304/Epilepsy patients face a significantly elevated risk of skeletal fractures, estimated to be two to seven times higher than in individuals without epilepsy. This increased vulnerability is attributed to multiple factors, including the direct impact of seizures, fall-related injuries during seizure ep
- What Will Be Tysabri's Fate?https://practicalneurology.com/columns/practice-management/what-will-be-tysabris-fate/31328/Natalizumab (Tysabri) in Multiple Sclerosis: Breakthroughs and ChallengesOver the past decades, advancements in understanding multiple sclerosis (MS) pathogenesis have paved the way for targeted therapies aimed at disrupting the inflammatory processes that drive central nervous system (CNS) inflamma
- Pregnancy Prevention in Epilepsy: Assessing the Optionshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0206PregnancyEpilepsy-pdf/31346/Epilepsy significantly affects the quality of life for women, particularly in areas of professional, academic, and social functioning. For women of childbearing age, managing epilepsy intersects critically with family planning and reproductive health decisions. However, there is a notable gap in the
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN1105epilepsy-pdf/31375/Managing epilepsy in individuals with intellectual disabilities (ID) presents significant challenges for healthcare professionals. Epilepsy prevalence in the general population ranges from 1-3%, but among those with ID, it escalates to between 30-50%. The likelihood of seizures increases with the se